foxo4 dri senolytic peptide human trials Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI | FOXO4/p53 Interaction Blocker
FOXO4 DRI FOXO4 p53 Interaction Blocker MedChemExpress Buy FOXO4 DRI Exceptional 99%+ Purity Third Party COA Included The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) Buy FOXO4 DRI 10mg Third Party Tested BioEdge Peptides FOXO4 DRI UK Senolytic Peptide Research Peptides Lab UK
Pay in 4 interest-free payments of $7.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10





